Co-Activation of STAT3 and YAP1 Signaling Pathways Limits EGFR Inhibitor Response in Lung Cancer

被引：0

作者：

Karachaliou, Niki ^{[1
]}

Chaib, Imane ^{[2
]}

Cardona, Andres ^{[3
]}

Lopez-Vivanco, Guillermo ^{[4
]}

Vergnenegre, Alain ^{[5
]}

Miguel Sanchez, Jose ^{[6
]}

Provencio, Mariano ^{[7
]}

De Marinis, Filippo ^{[8
]}

Passaro, Antonio ^{[8
]}

Carcereny, Enric ^{[9
]}

Reguart, Noemi ^{[10
]}

Garcia Campelo, Rosario ^{[11
]}

Santarpia, Mariacarmela ^{[12
]}

Viteri, Santiago ^{[1
]}

Molina Vila, Miguel Angel ^{[13
]}

Li, Xuefei ^{[14
]}

Zhou, Caicun ^{[15
]}

Moran, Teresa ^{[9
]}

Ramirez Serrano, Jose Luis ^{[2
,16
]}

Bivona, Trever ^{[17
]}

Ma, Patrick ^{[18
]}

Drozdowskyj, Ana ^{[19
]}

Cao, Peng ^{[20
]}

Rosell, Rafael ^{[21
]}

机构：

[1] Hosp Univ Quiron Dexeus, IOR, Barcelona, Spain

[2] Inst Invest Ciencies Germans Trias & Pujol, Lab Cellular & Mol Biol, Badalona, Spain

[3] Clin Country, Clin & Translat Oncol Grp, Bogota, Colombia

[4] Hosp Cruces, Baracaldo, Spain

[5] CHU Limoges, Limoges, France

[6] Hosp Univ La Princesa, Madrid, Spain

[7] Hosp Univ Puerta Hierro, Madrid, Spain

[8] European Inst Oncol, Div Thorac Oncol, Milan, Italy

[9] Catalan Inst Oncol Hospital Germans Trios & Pujol, Med Oncol, Badalona, Spain

[10] Hosp Clin Barcelona, Med Oncol, Barcelona, Spain

[11] Hosp Univ A Coruna, La Coruna, Spain

[12] Univ Messina, Oncol & Pathol, Messina, Italy

[13] Ior Quiron Dexeus Univ Inst, Pangaea Biotech Sl, Lab Cellular & Mol Biol, Barcelona, Spain

[14] Shanghai Pulm Hosp, Med Oncol, Shanghai, Peoples R China

[15] Tongji Univ, Sch Med, Shanghai Pulm Hosp, Dept Med Oncol, Shanghai, Peoples R China

[16] Catalan Inst Oncol, Lab Cellular & Mol Biol, Badalona, Spain

[17] UCSF, Med, San Francisco, CA USA

[18] Wvu Canc Inst, Morgantown, WV USA

[19] Pivotal Sl, Stat, Madrid, Spain

[20] Nanjing Univ Chinese Med, Hosp Integrated Tradit Chinese & Western Med, Lab Cellular & Mol Biol, Nanjing, Jiangsu, Peoples R China

[21] Hosp Badalona Germans Trias & Pujol, Catalan Inst Oncol, Barcelona, Spain

来源：

JOURNAL OF THORACIC ONCOLOGY | 2017年 / 12卷 / 01期

关键词：

lung cancer; STAT3; signaling; EGFR Inhibitor; YAP1;

D O I：

10.1016/j.jtho.2016.11.1714

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

P3.02b-047

引用

页码：S1216 / S1217

页数：2

共 50 条

[21] YAP1 promotes multidrug resistance of small cell lung cancer by CD74-related signaling pathways
Song, Yongchun
Sun, Yanqin
Lei, Yingying
Yang, Kui
Tang, Ruixiang
CANCER MEDICINE, 2020, 9 (01): : 259 - 268
[22] FGFR1 Co-Activation Networks in Lung Cancer
Heasley, Lynn
JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S137 - S137
[23] Emodin sensitizes human pancreatic cancer cells to EGFR inhibitor through suppressing Stat3 signaling pathway
Wang, Zhaohong
Chen, Hui
Chen, Jingjing
Hong, Zhong
Liao, Yi
Zhang, Qiyu
Tong, Hongfei
CANCER MANAGEMENT AND RESEARCH, 2019, 11 : 8463 - 8473
[24] EGFR dependent expression of STAT3 (but not STAT1) in breast cancer
Berclaz, G
Altermatt, HJ
Rohrbach, V
Siragusa, A
Dreher, E
Smith, PD
INTERNATIONAL JOURNAL OF ONCOLOGY, 2001, 19 (06) : 1155 - 1160
[25] Activation of YAP1 Is Associated with Poor Prognosis and Response to Taxanes in Ovarian Cancer
Jeong, Woojin
Kim, Sang-Bae
Sohn, Bo Hwa
Park, Yun-Yong
Park, Eun Sung
Kim, Sang Cheol
Kim, Sung Soo
Johnson, Randy L.
Birrer, Michael
Bowtell, David S. L.
Mills, Gordon B.
Sood, Anil
Lee, Ju-Seog
ANTICANCER RESEARCH, 2014, 34 (02) : 811 - 817
[26] DDIAS promotes STAT3 activation by preventing STAT3 recruitment to PTPRM in lung cancer cells
Joo-Young Im
Bo-Kyung Kim
Kang-Woo Lee
So-Young Chun
Mi-Jung Kang
Misun Won
Oncogenesis, 9
[27] STAT3 activation promotes invasiveness and cancer stemness in lung cancer
Yeung, Sai Fung
Chan, Sze Man
Law, Chun Ho
Chan, Hoi Yin
Tsui, Kwok Wing
CANCER RESEARCH, 2023, 83 (07)
[28] DDIAS promotes STAT3 activation by preventing STAT3 recruitment to PTPRM in lung cancer cells
Im, Joo-Young
Kim, Bo-Kyung
Lee, Kang-Woo
Chun, So-Young
Kang, Mi-Jung
Won, Misun
ONCOGENESIS, 2020, 9 (01)
[29] A natural xanthone suppresses lung cancer growth and metastasis by targeting STAT3 and FAK signaling pathways
Zhao, Yinan
Zhang, Xuke
Li, Ying
Li, Yeling
Zhang, Han
Song, Ziteng
Xu, Jing
Guo, Yuanqiang
PHYTOMEDICINE, 2022, 102
[30] Gemcitabine induces apoptosis via JAK2/STAT3 signaling pathways in lung cancer
Zhang, Ze-Yu
Zhang, Yan
Fu, Hong
Wang, Jing
Zheng, Zhi-Qin
Dong, Qiu-An
INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2016, 9 (02): : 2166 - 2174

← 1 2 3 4 5 →